loadpatents
name:-1.3220269680023
name:-0.13875913619995
name:-0.016499996185303
SCHEIFLINGER; Friedrich Patent Filings

SCHEIFLINGER; Friedrich

Patent Applications and Registrations

Patent applications and USPTO patent grants for SCHEIFLINGER; Friedrich.The latest application filed is for "use of recombinant adamts13 for treating sickle cell disease".

Company Profile
15.92.97
  • SCHEIFLINGER; Friedrich - Vienna AT
  • Scheiflinger; Friedrich - Wien AT
  • Scheiflinger; Friedrich - Orth/Donau AT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use Of Recombinant Adamts13 For Treating Sickle Cell Disease
App 20220249628 - ROSSATO; Paolo ;   et al.
2022-08-11
Anti-MIF immunohistochemistry
Grant 11,402,388 - Thiele , et al. August 2, 2
2022-08-02
Viral Vectors Encoding Recombinant Fviii Variants With Increased Expression For Gene Therapy Of Hemophilia A
App 20220213172 - Falkner; Falko-Gunter ;   et al.
2022-07-07
Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A
Grant 11,254,731 - Falkner , et al. February 22, 2
2022-02-22
Use Of Adamts13 For Treating, Ameliorating And/or Preventing Vaso-occlusive Crisis In Sickle Cell Disease, Acute Lung Injury And/or Acute Respiratory Distress Syndrome
App 20220047688 - EWENSTEIN; Bruce ;   et al.
2022-02-17
Adamts13-containing Compositions Having Thrombolytic Activity
App 20220002703 - Wagner; Denisa D. ;   et al.
2022-01-06
Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome
Grant 11,191,818 - Ewenstein , et al. December 7, 2
2021-12-07
Compositions of human prothrombin and activated factor X for improving hemostasis in the treatment of bleeding disorders
Grant 11,160,850 - Dockal , et al. November 2, 2
2021-11-02
ADAMTS13-containing compositions having thrombolytic activity
Grant 11,124,787 - Wagner , et al. September 21, 2
2021-09-21
Combination Therapy Of Anti-mif Antibodies And Glucocorticoids
App 20210187105 - Kerschbaumer; Randolf ;   et al.
2021-06-24
TFPI inhibitors and methods of use
Grant 11,001,613 - Dockal , et al. May 11, 2
2021-05-11
Viral Vectors Encoding Recombinant Fix With Increased Expression For Gene Therapy Of Hemophilia B
App 20210128700 - Horling; Franziska ;   et al.
2021-05-06
Compositions Comprising Adamts13 For Use In Methods For The Recanalization Of Occluded Blood Vessels In An Infarction
App 20210128701 - PLAIMAUER; Barbara ;   et al.
2021-05-06
Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia B
Grant 10,842,853 - Horling , et al. November 24, 2
2020-11-24
Biologically active peptides
Grant 10,822,376 - Scheiflinger , et al. November 3, 2
2020-11-03
TFPI inhibitors and methods of use
Grant 10,800,816 - Dockal , et al. October 13, 2
2020-10-13
Viral Vectors Encoding Recombinant Fviii Variants With Increased Expression For Gene Therapy Of Hemophilia A
App 20200289672 - Rottensteiner; Hanspeter ;   et al.
2020-09-17
Gene Therapy Of Hemophilia B Using Viral Vectors Encoding Recombinant Fix Variants With Increased Expression
App 20200246437 - Kind Code
2020-08-06
Use Of Adamts13 For Treating, Ameliorating And/or Preventing Vaso-occlusive Crisis In Sickle Cell Disease, Acute Lung Injury And
App 20190336588 - EWENSTEIN; Bruce ;   et al.
2019-11-07
Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding Disorders
App 20190231855 - Dockal; Michael ;   et al.
2019-08-01
Biologically Active Peptides
App 20190225648 - Scheiflinger; Friedrich ;   et al.
2019-07-25
Viral Vectors Encoding Recombinant Fviii Variants With Increased Expression For Gene Therapy Of Hemophilia A
App 20190202893 - Falkner; Falko-Gunter ;   et al.
2019-07-04
Viral Vectors Encoding Recombinant Fviii Variants With Increased Expression For Gene Therapy Of Hemophilia A
App 20190194295 - Falkner; Falko-Gunter ;   et al.
2019-06-27
Adamts13-containing Compositions Having Thrombolytic Activity
App 20190161746 - Wagner; Denisa D. ;   et al.
2019-05-30
Biologically active peptides
Grant 10,287,319 - Scheiflinger , et al.
2019-05-14
Tfpi Inhibitors And Methods Of Use
App 20190134147 - Dockal; Michael ;   et al.
2019-05-09
Factor VIIa-polysialic acid conjugates having prolonged in vivo half-life
Grant 10,251,941 - Turecek , et al.
2019-04-09
ADAMTS13-containing compositions having thrombolytic activity
Grant 10,233,436 - Wagner , et al.
2019-03-19
TFPI inhibitors and methods of use
Grant 10,201,586 - Dockal , et al. Feb
2019-02-12
Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A
Grant 10,189,889 - Falkner , et al. Ja
2019-01-29
Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A
Grant 10,189,888 - Falkner , et al. Ja
2019-01-29
Viral Vectors Encoding Recombinant Fix With Increased Expression For Gene Therapy Of Hemophilia B
App 20180339026 - Horling; Franziska ;   et al.
2018-11-29
Peptides and methods of use
Grant 10,124,033 - Dockal , et al. November 13, 2
2018-11-13
Combination Therapy Of Anti-mif Antibodies And Glucocorticoids
App 20180280501 - Kerschbaumer; Randolf ;   et al.
2018-10-04
Tfpi Inhibitors And Methods Of Use
App 20180155399 - DOCKAL; Michael ;   et al.
2018-06-07
OxMIF as a diagnostic marker
Grant 9,958,456 - Thiele , et al. May 1, 2
2018-05-01
Compositions Comprising Adamts13 For Use In Methods For The Recanalization Of Occluded Blood Vessels In An Infarction
App 20180110842 - PLAIMAUER; Barbara ;   et al.
2018-04-26
Tfpi Inhibitors And Methods Of Use
App 20180072784 - DOCKAL; Michael ;   et al.
2018-03-15
TFPI inhibitors and methods of use
Grant 9,873,720 - Dockal , et al. January 23, 2
2018-01-23
TFPI inhibitors and methods of use
Grant 9,777,051 - Dockal , et al. October 3, 2
2017-10-03
Viral Vectors Encoding Recombinant Fviii Variants With Increased Expression For Gene Therapy Of Hemophilia A
App 20170233455 - Falkner; Falko-Gunter ;   et al.
2017-08-17
Viral Vectors Encoding Recombinant Fviii Variants With Increased Expression For Gene Therapy Of Hemophilia A
App 20170226188 - Falkner; Falko-Gunter ;   et al.
2017-08-10
Recombinant Co-expression Of Vitamin K Epoxide Reductase Subunit 1 To Improve Vitamin K Dependent Protein Expression
App 20170226487 - Scheiflinger; Friedrich ;   et al.
2017-08-10
Biologically Active Peptides
App 20170174724 - Scheiflinger; Friedrich ;   et al.
2017-06-22
Tfpi Inhibitors And Methods Of Use
App 20170174727 - DOCKAL; MICHAEL ;   et al.
2017-06-22
Tfpi Inhibitors And Methods Of Use
App 20170157198 - Dockal; Michael ;   et al.
2017-06-08
Nucleic acids encoding vitamin K expoxide reductase subunit 1 and vitamin K dependent protein expression and methods of using same
Grant 9,617,523 - Scheiflinger , et al. April 11, 2
2017-04-11
Biologically active peptides
Grant 9,598,464 - Scheiflinger , et al. March 21, 2
2017-03-21
Composition Exhibiting a von Willebrand Factor (vWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence AAGGILHLELLV
App 20170065686 - Laemmle; Bernhard ;   et al.
2017-03-09
Combination Therapy Of Anti-mif Antibodies And Chemotherapeutics
App 20170049885 - Kerschbaumer; Randolf ;   et al.
2017-02-23
Preparations based on fibrinogen and sulfated polysaccharides
Grant 9,566,364 - Dockal , et al. February 14, 2
2017-02-14
Peptides And Methods Of Use
App 20170035835 - Dockal; Michael ;   et al.
2017-02-09
TFPI inhibitors and methods of use
Grant 9,556,230 - Dockal , et al. January 31, 2
2017-01-31
Von willebrand factor- and factor VIII-polymer conjugates having a releasable linkage
Grant 9,493,544 - Bossard , et al. November 15, 2
2016-11-15
Characterization of CHO-MIF gene and protein, and use thereof
Grant 9,465,037 - Kerschbaumer , et al. October 11, 2
2016-10-11
Peptides and methods of use
Grant 9,447,147 - Dockal , et al. September 20, 2
2016-09-20
Methods and systems for screening compositions comprising non-anticoagulant sulfated polysaccharides
Grant 9,417,251 - Dockal , et al. August 16, 2
2016-08-16
Treatment Of Coagulation Disease By Administration Of Recombinant Vwf
App 20160184403 - Scheiflinger; Friedrich ;   et al.
2016-06-30
Factor Viia-polysialic Acid Conjugates Having Prolonged In Vivo Half-life
App 20160129121 - Turecek; Peter ;   et al.
2016-05-12
Composition exhibiting a von Willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV
Grant 9,309,506 - Laemmle , et al. April 12, 2
2016-04-12
Biologically Active Peptides
App 20160060295 - Scheiflinger; Friedrich ;   et al.
2016-03-03
Treatment of coagulation disease by administration of recombinant VWF
Grant 9,272,021 - Scheiflinger , et al. March 1, 2
2016-03-01
Biologically active peptides
Grant 9,206,234 - Scheiflinger , et al. December 8, 2
2015-12-08
Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding Disorders
App 20150258182 - Dockal; Michael ;   et al.
2015-09-17
Combination Therapy Of Anti-mif Antibodies And Glucocorticoids
App 20150250873 - Kerschbaumer; Randolf ;   et al.
2015-09-10
Peptides And Methods Of Use
App 20150246947 - Dockal; Michael ;   et al.
2015-09-03
Tfpi Inhibitors And Methods Of Use
App 20150232514 - Dockal; Michael ;   et al.
2015-08-20
Anti-mif Immunohistochemistry
App 20150160235 - Thiele; Michael ;   et al.
2015-06-11
Methods and compositions for treating bleeding disorders
Grant 9,046,536 - Dockal , et al. June 2, 2
2015-06-02
TFPI inhibitors and methods of use
Grant 9,018,167 - Dockal , et al. April 28, 2
2015-04-28
Combination Therapy Of Anti-mif Antibodies And Chemotherapeutics
App 20150071942 - Kerschbaumer; Randolf ;   et al.
2015-03-12
TFPI inhibitors and methods of use
Grant 8,962,563 - Dockal , et al. February 24, 2
2015-02-24
Biologically Active Peptides
App 20150038676 - SCHEIFLINGER; FRIEDRICH ;   et al.
2015-02-05
Anti Mif Antibodies
App 20150023978 - Kerschbaumer; Randolf ;   et al.
2015-01-22
Composition Exhibiting a von Willebrand Factor (vWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence AAGGILHLELLV
App 20140335071 - Laemmle; Bernhard ;   et al.
2014-11-13
Characterization Of Cho-mif Gene And Protein, And Use Thereof
App 20140287443 - Kerschbaumer; Randolf J. ;   et al.
2014-09-25
Polymer von Willebrand factor-conjugates
Grant 8,835,388 - Scheiflinger , et al. September 16, 2
2014-09-16
Oxmif As A Diagnostic Marker
App 20140248638 - Thiele; Michael ;   et al.
2014-09-04
Procoagulant peptides
Grant 8,822,638 - Scheiflinger , et al. September 2, 2
2014-09-02
Immunoadsorption of anti-von Willebrand factor cleaving protease antibodies
Grant 8,795,999 - Scheiflinger , et al. August 5, 2
2014-08-05
Factor Viia-polysialic Acid Conjugates Having Prolonged In Vivo Half-life
App 20140186323 - Turecek; Peter ;   et al.
2014-07-03
Composition exhibiting a von Willebrand Factor (vWF) protease activity with the amino acid sequence AAGGILHLELLV
Grant 8,703,426 - Laemmle , et al. April 22, 2
2014-04-22
Composition exhibiting a von Willebrand Factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV
Grant 8,703,429 - Laemmle , et al. April 22, 2
2014-04-22
Anti MIF antibodies
Grant 8,668,909 - Kerschbaumer , et al. March 11, 2
2014-03-11
Methods And Systems For Screening Compositions Comprising Non-anticoagulant Sulfated Polysaccharides
App 20140051657 - Dockal; Michael ;   et al.
2014-02-20
Methods for Treating Bleeding Disorders
App 20140050717 - Dockal; Michael ;   et al.
2014-02-20
Factor VIIa-polysialic acid conjugate having prolonged in vivo half-life
Grant 8,637,007 - Turecek , et al. January 28, 2
2014-01-28
Methods and compositions for treating bleeding disorders
Grant 8,632,991 - Dockal , et al. January 21, 2
2014-01-21
Method of treating a patient suffering from a bleeding disorder comprising administering an antibody against the A3-C1 of FVIII
Grant 8,586,538 - Mertens , et al. November 19, 2
2013-11-19
Methods and Compositions for Treating Bleeding Disorders
App 20130302820 - Dockal; Michael ;   et al.
2013-11-14
Procoagulant peptides
Grant 8,563,688 - Scheiflinger , et al. October 22, 2
2013-10-22
Tfpi Inhibitors And Methods Of Use
App 20130274193 - Dockal; Michael ;   et al.
2013-10-17
Aptamers To Tissue Factor Pathway Inhibitor And Their Use As Bleeding Disorder Therapeutics
App 20130267584 - Dockal; Michael ;   et al.
2013-10-10
Tfpi Inhibitors And Methods Of Use
App 20130259863 - Dockal; Michael ;   et al.
2013-10-03
Method for identifying a non-anticoagulant sulfated polysaccharide which enhances blood coagulation dependence on FXI
Grant 8,546,096 - Dockal , et al. October 1, 2
2013-10-01
Factor VIII polypeptide having factor VIII:C activity
Grant 8,546,332 - Lenting , et al. October 1, 2
2013-10-01
Tfpi Inhibitors And Methods Of Use
App 20130252896 - Dockal; Michael ;   et al.
2013-09-26
FVIII-independent FIX-mutant proteins for hemophilia a treatment
Grant 8,513,386 - Dockal , et al. August 20, 2
2013-08-20
Polymer-Von Willebrand Factor-Conjugates
App 20130190242 - Scheiflinger; Friedrich ;   et al.
2013-07-25
TFPI inhibitors and methods of use
Grant 8,466,108 - Dockal , et al. June 18, 2
2013-06-18
Procedure For The Generation Of A High Producer Cell Line For The Expression Of A Recombinant Anti-cd34 Antibody
App 20130143238 - Kerschbaumer; Randolf ;   et al.
2013-06-06
Adamts13-containing Compositions Having Thrombolytic Activity
App 20130136732 - Wagner; Denisa ;   et al.
2013-05-30
TFPI inhibitors and methods of use
Grant 8,450,275 - Dockal , et al. May 28, 2
2013-05-28
Methods and compositions for treating bleeding disorders
Grant 8,435,792 - Dockal , et al. May 7, 2
2013-05-07
Procedure for the generation of a high producer cell line for the expression of a recombinant anti-CD34 antibody
Grant 8,399,249 - Kerschbaumer , et al. March 19, 2
2013-03-19
Polymer-von Willebrand factor-conjugates
Grant 8,357,779 - Scheiflinger , et al. January 22, 2
2013-01-22
Von Willebrand Factor- And Factor Viii-polymer Conjugates Having A Releasable Linkage
App 20130012442 - Bossard; Mary J. ;   et al.
2013-01-10
Von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage
Grant 8,349,800 - Bossard , et al. January 8, 2
2013-01-08
Detection Of Circulating Adamts13-antibody Complexes
App 20120315650 - Ferrari; Silvia ;   et al.
2012-12-13
Treatment Of Coagulation Disease By Administration Of Recombinant Vwf
App 20120316116 - Scheiflinger; Friedrich ;   et al.
2012-12-13
Von Willebrand Factor- and Factor VIII-Polymer Conjugates Having a Releasable Linkage
App 20120142594 - Bossard; Mary J. ;   et al.
2012-06-07
Polymer-Von Willebrand Factor-Conjugates
App 20120135462 - Scheiflinger; Friedrich ;   et al.
2012-05-31
Biologically Active Peptides
App 20120077749 - Scheiflinger; Friedrich ;   et al.
2012-03-29
von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage
Grant 8,133,865 - Bossard , et al. March 13, 2
2012-03-13
Tfpi Inhibitors And Methods Of Use
App 20120028901 - DOCKAL; MICHAEL ;   et al.
2012-02-02
Polymer-von Willebrand factor-conjugates
Grant 8,076,463 - Scheiflinger , et al. December 13, 2
2011-12-13
Methods and Compositions for Treating Bleeding Disorders
App 20110244478 - Dockal; Michael ;   et al.
2011-10-06
FVIII-independent FIX-mutant proteins for hemophilia A treatment
Grant 8,022,187 - Dockal , et al. September 20, 2
2011-09-20
Methods And Compositions For Treating Bleeding Disorders
App 20110172156 - Dockal; Michael ;   et al.
2011-07-14
Factor Viii Polypeptide Having Factor Viii:c Activity
App 20110118188 - LENTING; PETRUS JOHANNES ;   et al.
2011-05-19
Diagnostic assay for anti-von Willebrand Factor cleaving protease (ADAMTS13) antibodies
Grant 7,943,326 - Scheiflinger , et al. May 17, 2
2011-05-17
Methods for Treating Bleeding Disorders
App 20110110921 - Dockal; Michael ;   et al.
2011-05-12
Polymer-Von Willebrand Factor-Conjugates
App 20110111455 - Scheiflinger; Friedrich ;   et al.
2011-05-12
Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV
Grant 7,910,094 - Laemmle , et al. March 22, 2
2011-03-22
Polymer-factor VIII-von Willebrand factor-conjugates
Grant 7,884,075 - Scheiflinger , et al. February 8, 2
2011-02-08
Diagnostic Assay For Anti-von Willebrand Factor Cleaving Protease (adamts13) Antibodies
App 20100273183 - Scheiflinger; Friedrich ;   et al.
2010-10-28
Anti Mif Antibodies
App 20100260768 - Kerschbaumer; Randolf ;   et al.
2010-10-14
Diagnostic assay for anti-von Willebrand Factor cleaving protease (ADAMTS13) antibodies
Grant 7,763,430 - Scheiflinger , et al. July 27, 2
2010-07-27
Tfpi Inhibitors And Methods Of Use
App 20100173847 - Dockal; Michael ;   et al.
2010-07-08
Preparations Based On Fibrinogen And Sulfated Polysaccharides
App 20100166834 - Dockal; Michael ;   et al.
2010-07-01
Biologically Active Peptides
App 20100022445 - SCHEIFLINGER; FRIEDRICH ;   et al.
2010-01-28
Immunoadsorption Of Anti-von Willebrand Factor Cleaving Protease Antibodies
App 20090264631 - Scheiflinger; Friedrich ;   et al.
2009-10-22
Anti MIF Antibodies
App 20090220521 - Kerschbaumer; Randolf ;   et al.
2009-09-03
Procedure For The Generation Of A High Producer Cell Line For The Expression Of A Recombinant Anti-cd34 Antibody
App 20090221003 - Kerschbaumer; Randolf ;   et al.
2009-09-03
Highly phosphorylated and sulfated recombinant factor IX
Grant 7,575,897 - Scheiflinger , et al. August 18, 2
2009-08-18
COMPOSITION EXHIBITING A VON WILLEBRAND FACTOR (vWF) PROTEASE ACTIVITY COMPRISING A POLYPEPTIDE CHAIN WITH THE AMINO ACID SEQUENCE AAGGILHLELLV
App 20090203110 - Laemmle; Bernhard ;   et al.
2009-08-13
Chemically Modified Factor Ix
App 20090176708 - Turecek; Peter ;   et al.
2009-07-09
Factor VIII polypeptide having factor VIII:C activity
Grant 7,544,660 - Lenting , et al. June 9, 2
2009-06-09
Composition exhibiting a von Willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV
Grant 7,501,117 - Laemmle , et al. March 10, 2
2009-03-10
COMPOSITION EXHIBITING A VON WILLEBRAND FACTOR (vWF) PROTEASE ACTIVITY COMPRISING A POLYPEPTIDE CHAIN WITH THE AMINO ACID SEQUENCE AAGGILHLELLV
App 20090017467 - Laemmle; Bernhard ;   et al.
2009-01-15
Von Willebrand factor-and factor VIII-polymer conjugates having a releasable linkage
App 20080234193 - Bossard; Mary J. ;   et al.
2008-09-25
Factor VIIa-Polysialic Acid Conjugate Having Prolonged In Vivo Half-Life
App 20080221032 - Turecek; Peter ;   et al.
2008-09-11
Antagonists of Factor VIII Interaction with Low-Density Lipoprotein Receptor Related Protein
App 20080219983 - Mertens; Koenraad ;   et al.
2008-09-11
FVIII-Independent FIX-Mutant Proteins for Hemophilia A Treatment
App 20080214461 - Dockal; Michael ;   et al.
2008-09-04
FIX-Mutant Proteins for Hemophilia B Treatment
App 20080214462 - Dockal; Michael ;   et al.
2008-09-04
Highly Phosphorylated And Sulfated Recombinant Factor Ix
App 20080176287 - Scheiflinger; Friedrich ;   et al.
2008-07-24
Composition Exhibiting a von Willebrand Factor (vWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence AAGGILHLELLV
App 20080176312 - Laemmle; Bernhard ;   et al.
2008-07-24
Highly phosphorylated and sulfated recombinant factor IX
Grant 7,375,084 - Scheiflinger , et al. May 20, 2
2008-05-20
Factor IXa specific antibodies displaying factor VIIIa like activity
Grant 7,297,336 - Kerschbaumer , et al. November 20, 2
2007-11-20
Highly Phosphorylated And Sulfated Recombinant Factor Ix
App 20070244036 - Scheiflinger; Friedrich ;   et al.
2007-10-18
Factor IX/factor IXa activating antibodies and antibody derivatives
Grant 7,279,161 - Scheiflinger , et al. October 9, 2
2007-10-09
ADAMTS13-containing compositions having thrombolytic activity
App 20070015703 - Wagner; Denisa ;   et al.
2007-01-18
Recombinant co-expression of vitamin K epoxide reductase subunit 1 to improve vitamin K dependent protein expression
App 20060194284 - Scheiflinger; Friedrich ;   et al.
2006-08-31
Polymer-von Willebrand factor-conjugates
App 20060160948 - Scheiflinger; Friedrich ;   et al.
2006-07-20
Factor VIII polypeptide having factor VIII:C activity
App 20060160994 - Lenting; Petrus Johannes ;   et al.
2006-07-20
Factor IX/factor IXa activating antibodies and antibody derivatives
Grant 7,033,590 - Scheiflinger , et al. April 25, 2
2006-04-25
Factor IX/factor IXa activating antibodies and antibody derivatives
App 20050196397 - Scheiflinger, Friedrich ;   et al.
2005-09-08
Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV
Grant 6,926,894 - Laemmle , et al. August 9, 2
2005-08-09
Factor VII polypeptide having factor VII:C activity
Grant 6,919,311 - Lenting , et al. July 19, 2
2005-07-19
Factor Viii Polypeptide Having Factor Viii:c Activity
App 20050074836 - Lenting, Petrus Johannes ;   et al.
2005-04-07
Factor IXa specific antibodies displaying factor VIIIa like activity
App 20050058640 - Kerschbaumer, Randolf ;   et al.
2005-03-17
Diagnostic assay for anti-von willebrand factor cleaving protease ( ADAMTS13) antibodies
App 20040214346 - Scheiflinger, Friedrich ;   et al.
2004-10-28
Immunoadsorption of anti-von Willebrand Factor cleaving protease antibodies
App 20040185042 - Scheiflinger, Friedrich ;   et al.
2004-09-23
Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV
App 20020136713 - Laemmle, Bernhard ;   et al.
2002-09-26
Targeted angiogenesis
App 20020019350 - Levine, Arnold J. ;   et al.
2002-02-14
Direct molecular cloning of foreign genes into poxviruses and methods for the preparation of recombinant proteins
Grant 6,265,183 - Dorner , et al. July 24, 2
2001-07-24
Methods for generating immune responses employing modified vaccinia of fowlpox viruses
Grant 6,103,244 - Dorner , et al. August 15, 2
2000-08-15
Direct molecular cloning of a modified poxvirus genome
Grant 5,445,953 - Dorner , et al. August 29, 1
1995-08-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed